Human immunodeficiency virus - Associated obliterative portopathy underlies unexplained aminotransferase elevations under antiretrovirals

Hepatology

Volumn 50, Issue 2, 2009, Pages 660-

  Mallet, Vincent O ^a,b,c   Vallet Pichard, Anaïs ^a,b,c   Pol, Stanislas ^a,b,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Unité 567 Institut National de la Santé et de la Recherche Médicale ^*  (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIRETROVIRUS AGENT; ASPARTATE AMINOTRANSFERASE; DIDANOSINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; PROTEIN C; PROTEIN S;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; BLOOD CLOTTING TEST; CHRONIC LIVER DISEASE; COMPUTER ASSISTED TOMOGRAPHY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS OBLITERATIVE PORTOPATHY; LETTER; LIVER DISEASE; LIVER TRANSPLANTATION; PORTAL HYPERTENSION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN S DEFICIENCY; BLOOD; NOTE;

ALANINE TRANSAMINASE; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ASPARTATE AMINOTRANSFERASES; HIV INFECTIONS; HUMANS; LIVER DISEASES;

EID: 68949183164     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22957     Document Type: Letter

References (8)

1. Ingiliz P, Valantin MA, Duvivier C, Medja F, Dominguez S, Charlotte F, et al. Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapy. HEPATOLOGY 2009;49:436-442.
2. Bani-Sadr F, Carrat F, Bedossa P, Piroth L, Cacoub P, Perronne C, et al. Hepatic steatosis in HIV-HCV coinfected patients: analysis of risk factors. Aids 2006;20:525-531. (Pubitemid 43731596)
3. Maida I, Nunez M, Rios MJ, Martin-Carbonero L, Sotgiu G, Toro C, et al. Severe liver disease associated with prolonged exposure to antiretroviral drugs. J Acquir Immune Defic Syndr 2006;42:177-182. (Pubitemid 43884712)
4. Mallet V, Blanchard P, Verkarre V, Vallet-Pichard A, Fontaine H, Lascoux-Combe C, et al. Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients. Aids 2007;21:187-192. (Pubitemid 46036926)
5. Schiano TD, Kotler DP, Ferran E, Fiel MI. Hepatoportal sclerosis as a cause of noncirrhotic portal hypertension in patients with HIV. Am J Gastroenterol 2007;102:2536-2540. (Pubitemid 47631766)
6. Tateo M, Sebagh M, Bralet MP, Teicher E, Azoulay D, Mallet V, et al. A new indication for liver transplantation: nodular regenerative hyperplasia in human immunodeficiency virus-infected patients. Liver Transpl 2008;14:1194-1198.
7. Mallet V, Varthaman A, Lasne D, Viard JP, Vallet-Pichard A, Fontaine H, et al. Human immunodeficiency virus-associated nodular regenerative hyperplasia is linked to portal obstructive venopathy and autoimmune protein S deficiency. Paper presented at: 58th Annual Meeting of the American Association for the Study of Liver Diseases; November 2-6, 2007; Boston, MA. Paper 764.
8. Mallet V, Varthaman A, Gouya H, Lasne D, Viard JP, Lacroix-Desmazes S, et al. Acquired protein S deficiency leads to HIV-associated obliterative portopathy (HIV-OP) and nodular regenerative hyperplasia. Paper presented at: 59th Annual Meeting of the American Association for the Study of Liver Diseases; October 31 to November 4, 2008; San Francisco, CA. Paper 1757.